Lumbar bone mineral density in prostate cancer patients with bone metastases

Endocrine Research

Volumn 29, Issue 2, 2003, Pages 177-182

  Chang, Chao Hsiang ^a   Tsai, Chang Shu ^a   Jim, Yick Fung ^a   Wu, Hsi Chin ^a   Lin, Cheng Chieh ^a   Kao, Albert ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

Author keywords

Bone metastases; Bone mineral density; Prostate cancers

Indexed keywords

ETIDRONIC ACID TC 99M;

AGE; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE DEVELOPMENT; BONE METASTASIS; BONE MINERAL; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; LUMBAR SPINE; MALE; MEASUREMENT; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATE CANCER; SPINE METASTASIS; SPINE SCINTISCANNING;

AGED; BONE DENSITY; BONE NEOPLASMS; CARCINOMA; DENSITOMETRY, X-RAY; HUMANS; LUMBAR VERTEBRAE; MALE; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; SPINAL NEOPLASMS; TECHNETIUM TC 99M MEDRONATE;

EID: 0038007189     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-120022298     Document Type: Article

References (19)

1. Department of Health, the Executive Yuan. Cancer registery annual report, Republic of China, Taipei, 2000.
2. Department of Health, the Executive Yuan. Health Statistics 1991-2000.
3. Ministry of Interior. Papers of Population Policy, Taipei, 2001.
4. Delbarre F, Ghozian R, Amor B. Metastases osseuses avec ostéomalacie au cours de cancer de la prostate. Presse Méd 1975; 4:1277-1278.
5. Franck JL, Bouteiller G, Fauchier C, Sarramon JP, Arlet J. Profil biologique et histologique d'ostéomalacie dans I'ostéose condensante prostatique: a propos de 4 observations. Rev Rhum 1982; 49:81-85.
6. Hosking DJ, Chamberlain MJ, Shortland-Webb WR. Osteomalacie and carcinoma of prostate with major redistribution of skeletal calcium. Br J Radiol 1975; 48:451-456.
7. Mundy GR, Martin TJ. Pathophysiology of skeletal complications of cancer. In: Mundy GR, Martin TJ, eds. Physiology and Pharmacology of Bone. Springer: Berlin, 1993: 641-671.
8. Clarke NW, McClure J, George NJ. Osteoblast function and osteomalacia in metastatic prostate cancer. Eur Urol 1993; 24:286-290.
9. Linehan WM, Andriole GL. Endocrine aspects of urologic oncology. In: Graham SD, ed. Urologic Oncology. New York: Raven Press, 1986:75-86.
10. Sartoris DJ, Resnick D. Dual-energy radiographic absorptiometry for bone densitometry: current status and perspective. AJR 1989;152:241-246.
11. Rico H, Chapado MS, Revilla M, Bethencourt F, Villa LF, Guil M. Total and regional bone mass in metastatic cancer of the prostate. Eur Urol 1996;30:73-76.
12. Tanaka H, Furukawa Y, Fukunaga K, Fukunaga M. Bone mineral density for patients with bone metastasis of prostate cancer: a preliminary report. Adv Exp Med Biol 1992; 324:217-231.
13. Jocobson AF. Bone scanning in metastatic disease. In: Collier BD Jr, Fogelman I, Rosenthall L, eds. Skeletal Nuclear Medicine. St. Louis: Mobsy, 1996:87-123.
14. Resnick D. Skeletal metastases. In: Resnick D, ed. Bone and Joint Imaging. Philadelphia: WB Saunders, 1996:1076-1091.
15. Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology 1996; 199:751-756.
16. Galasko CSB. Skeletal metastases. Clin Orthop 1986; 210:18-30.
17. Tofe AJ, Francis MD, Harvey WJ. Correlation of neoplasm with incidence and localization of skeletal metastases: an analysis of 1355 diphosphonate bone scans. J J Nucl Med 1975; 16:986-989.
18. Daniell HW. Osteoporosis due to androgen deprivation therapy in men with prostate cancer. Urology 2001; 58:101-107.
19. Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H. Detection of bony metastases of androgen-independent prostate cancer by FDG-PET. Nucl Med Biol 1996; 23:693-697.